Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure.

BACKGROUND: The paraventricular nucleus (PVN) of the hypothalamus plays an important role in the progression of heart failure (HF). We investigated whether cyclooxygenase-2 (COX-2) inhibition in the PVN attenuates the activities of sympathetic nervous system (SNS) and renin-angiotensin system (RAS)...

Full description

Bibliographic Details
Main Authors: Min Zheng, Yu-Ming Kang, Wei Liu, Wei-Jin Zang, Cui-Yu Bao, Da-Nian Qin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3496718?pdf=render
_version_ 1817976091273330688
author Min Zheng
Yu-Ming Kang
Wei Liu
Wei-Jin Zang
Cui-Yu Bao
Da-Nian Qin
author_facet Min Zheng
Yu-Ming Kang
Wei Liu
Wei-Jin Zang
Cui-Yu Bao
Da-Nian Qin
author_sort Min Zheng
collection DOAJ
description BACKGROUND: The paraventricular nucleus (PVN) of the hypothalamus plays an important role in the progression of heart failure (HF). We investigated whether cyclooxygenase-2 (COX-2) inhibition in the PVN attenuates the activities of sympathetic nervous system (SNS) and renin-angiotensin system (RAS) in rats with adriamycin-induced heart failure. METHODOLOGY/PRINCIPAL FINDING: Heart failure was induced by intraperitoneal injection of adriamycin over a period of 2 weeks (cumulative dose of 15 mg/kg). On day 19, rats received intragastric administration daily with either COX-2 inhibitor celecoxib (CLB) or normal saline. Treatment with CLB reduced mortality and attenuated both myocardial atrophy and pulmonary congestion in HF rats. Compared with the HF rats, ventricle to body weight (VW/BW) and lung to body weight (LW/BW) ratios, heart rate (HR), left ventricular end-diastolic pressure (LVEDP), left ventricular peak systolic pressure (LVPSP) and maximum rate of change in left ventricular pressure (LV±dp/dtmax) were improved in HF+CLB rats. Angiotensin II (ANG II), norepinephrine (NE), COX-2 and glutamate (Glu) in the PVN were increased in HF rats. HF rats had higher levels of ANG II and NE in plasma, higher level of ANG II in myocardium, and lower levels of ANP in plasma and myocardium. Treatment with CLB attenuated these HF-induced changes. HF rats had more COX-2-positive neurons and more corticotropin releasing hormone (CRH) positive neurons in the PVN than did control rats. Treatment with CLB decreased COX-2-positive neurons and CRH positive neurons in the PVN of HF rats. CONCLUSIONS: These results suggest that PVN COX-2 may be an intermediary step for PVN neuronal activation and excitatory neurotransmitter release, which further contributes to sympathoexcitation and RAS activation in adriamycin-induced heart failure. Treatment with COX-2 inhibitor attenuates sympathoexcitation and RAS activation in adriamycin-induced heart failure.
first_indexed 2024-04-13T21:58:51Z
format Article
id doaj.art-082c23835ced465a9f6f30cc9b2391ca
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T21:58:51Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-082c23835ced465a9f6f30cc9b2391ca2022-12-22T02:28:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01711e4877110.1371/journal.pone.0048771Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure.Min ZhengYu-Ming KangWei LiuWei-Jin ZangCui-Yu BaoDa-Nian QinBACKGROUND: The paraventricular nucleus (PVN) of the hypothalamus plays an important role in the progression of heart failure (HF). We investigated whether cyclooxygenase-2 (COX-2) inhibition in the PVN attenuates the activities of sympathetic nervous system (SNS) and renin-angiotensin system (RAS) in rats with adriamycin-induced heart failure. METHODOLOGY/PRINCIPAL FINDING: Heart failure was induced by intraperitoneal injection of adriamycin over a period of 2 weeks (cumulative dose of 15 mg/kg). On day 19, rats received intragastric administration daily with either COX-2 inhibitor celecoxib (CLB) or normal saline. Treatment with CLB reduced mortality and attenuated both myocardial atrophy and pulmonary congestion in HF rats. Compared with the HF rats, ventricle to body weight (VW/BW) and lung to body weight (LW/BW) ratios, heart rate (HR), left ventricular end-diastolic pressure (LVEDP), left ventricular peak systolic pressure (LVPSP) and maximum rate of change in left ventricular pressure (LV±dp/dtmax) were improved in HF+CLB rats. Angiotensin II (ANG II), norepinephrine (NE), COX-2 and glutamate (Glu) in the PVN were increased in HF rats. HF rats had higher levels of ANG II and NE in plasma, higher level of ANG II in myocardium, and lower levels of ANP in plasma and myocardium. Treatment with CLB attenuated these HF-induced changes. HF rats had more COX-2-positive neurons and more corticotropin releasing hormone (CRH) positive neurons in the PVN than did control rats. Treatment with CLB decreased COX-2-positive neurons and CRH positive neurons in the PVN of HF rats. CONCLUSIONS: These results suggest that PVN COX-2 may be an intermediary step for PVN neuronal activation and excitatory neurotransmitter release, which further contributes to sympathoexcitation and RAS activation in adriamycin-induced heart failure. Treatment with COX-2 inhibitor attenuates sympathoexcitation and RAS activation in adriamycin-induced heart failure.http://europepmc.org/articles/PMC3496718?pdf=render
spellingShingle Min Zheng
Yu-Ming Kang
Wei Liu
Wei-Jin Zang
Cui-Yu Bao
Da-Nian Qin
Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure.
PLoS ONE
title Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure.
title_full Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure.
title_fullStr Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure.
title_full_unstemmed Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure.
title_short Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure.
title_sort inhibition of cyclooxygenase 2 reduces hypothalamic excitation in rats with adriamycin induced heart failure
url http://europepmc.org/articles/PMC3496718?pdf=render
work_keys_str_mv AT minzheng inhibitionofcyclooxygenase2reduceshypothalamicexcitationinratswithadriamycininducedheartfailure
AT yumingkang inhibitionofcyclooxygenase2reduceshypothalamicexcitationinratswithadriamycininducedheartfailure
AT weiliu inhibitionofcyclooxygenase2reduceshypothalamicexcitationinratswithadriamycininducedheartfailure
AT weijinzang inhibitionofcyclooxygenase2reduceshypothalamicexcitationinratswithadriamycininducedheartfailure
AT cuiyubao inhibitionofcyclooxygenase2reduceshypothalamicexcitationinratswithadriamycininducedheartfailure
AT danianqin inhibitionofcyclooxygenase2reduceshypothalamicexcitationinratswithadriamycininducedheartfailure